Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,555Revenue $M2,617Net Margin (%)-54.2Z-Score0.7
Enterprise Value $M16,253EPS $-6.1Operating Margin %-58.5F-Score4
P/E(ttm))0Cash Flow Per Share $7.2Pre-tax Margin (%)-66.9Higher ROA y-yN
Price/Book5.410-y EBITDA Growth Rate %0Quick Ratio1.1Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %0Current Ratio1.3Lower Leverage y-yN
Price/Cash Flow3.9y-y EBITDA Growth Rate %0ROA % (ttm)-16.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-71.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M154ROI % (ttm)-16.6Gross Margin Increase y-yN

Gurus Latest Trades with ENDP

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENDPGeorge Soros 2014-12-31 Buy 1.4%$60.19 - $73.37
($68.57)
$ 85.625%New holding, 1748729 sh.1,748,729
ENDPJohn Griffin 2014-12-31 Reduce-1.04%$60.19 - $73.37
($68.57)
$ 85.625%Reduce -22.63%4,409,000
ENDPJulian Robertson 2014-12-31 Sold Out -0.37%$60.19 - $73.37
($68.57)
$ 85.625%Sold Out0
ENDPJoel Greenblatt 2014-12-31 Sold Out -0.01%$60.19 - $73.37
($68.57)
$ 85.625%Sold Out0
ENDPJohn Griffin 2014-09-30 Reduce-0.77%$61.26 - $70.27
($65.73)
$ 85.630%Reduce -16.38%5,698,528
ENDPWallace Weitz 2014-09-30 Reduce-0.34%$61.26 - $70.27
($65.73)
$ 85.630%Reduce -17.65%721,950
ENDPJoel Greenblatt 2014-09-30 Reduce-0.07%$61.26 - $70.27
($65.73)
$ 85.630%Reduce -84.54%13,716
ENDPWallace Weitz 2014-06-30 Add0.81%$56.28 - $73.94
($66.81)
$ 85.628%Add 75.01%876,670
ENDPJoel Greenblatt 2014-06-30 Buy 0.08%$56.28 - $73.94
($66.81)
$ 85.628%New holding, 88697 sh.88,697
ENDPMario Gabelli 2014-06-30 Reduce$56.28 - $73.94
($66.81)
$ 85.628%Reduce -21.77%23,900
ENDPSteve Mandel 2014-06-30 Sold Out -1.2%$56.28 - $73.94
($66.81)
$ 85.628%Sold Out0
ENDPJohn Griffin 2014-06-30 Reduce-0.9%$56.28 - $73.94
($66.81)
$ 85.628%Reduce -14.81%6,815,000
ENDPGeorge Soros 2014-06-30 Sold Out -0.13%$56.28 - $73.94
($66.81)
$ 85.628%Sold Out0
ENDPJulian Robertson 2014-03-31 Buy 0.51%$64.3 - $81.49
($70.78)
$ 85.621%New holding, 22800 sh.22,800
ENDPGeorge Soros 2014-03-31 Buy 0.13%$64.3 - $81.49
($70.78)
$ 85.621%New holding, 198503 sh.198,503
ENDPWallace Weitz 2014-03-31 Add0.12%$64.3 - $81.49
($70.78)
$ 85.621%Add 12.33%500,920
ENDPJoel Greenblatt 2014-03-31 Sold Out -0.64%$64.3 - $81.49
($70.78)
$ 85.621%Sold Out0
ENDPRay Dalio 2014-03-31 Sold Out -0.01%$64.3 - $81.49
($70.78)
$ 85.621%Sold Out0
ENDPDavid Dreman 2014-03-31 Sold Out -0.01%$64.3 - $81.49
($70.78)
$ 85.621%Sold Out0
ENDPSteve Mandel 2013-12-31 Buy 1.3%$43.64 - $67.25
($57.05)
$ 85.650%New holding, 4340000 sh.4,340,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENDP is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ENDP George Soros 2014-12-311,748,7291.141.4New Buy
ENDP Wallace Weitz 2014-12-31767,5300.51.5+6.31%
ENDP - CALLJohn Griffin 2014-12-31676,6000.440.59
ENDP Mario Gabelli 2014-12-3119,9000.010.01-13.1%
ENDP John Griffin 2014-12-314,409,0002.873.9-22.63%
ENDP Julian Robertson 2014-12-31000Sold Out
ENDP Joel Greenblatt 2014-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ENDP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Upadhyay SuketuEVP, CFO 2014-11-14Buy3,700$66.9427.88view
HIGGINS ARTHUR JDirector 2014-08-05Buy3,500$65.6530.39view
DELUCCA JOHNDirector 2014-06-09Sell6,764$68.8324.36view
MANOGUE CAROLINE BExec. V.P., CLO & Secy 2014-05-29Sell175,033$72.0218.86view
DELUCCA JOHNDirector 2014-05-01Sell8,094$66.3129.09view
DELUCCA JOHNDirector 2014-04-01Sell10,384$68.4625.04view
Gergel Ivan P.EVP, R&D and CSO 2014-03-10Sell75,637$72.4718.12view
HIGGINS ARTHUR JDirector 2014-03-10Buy5,000$7317.26view
Hutson Nancy JDirector 2014-03-10Sell5,000$72.1218.69view
MANOGUE CAROLINE BExec. V.P., CLO & Secy 2013-08-26Sell145,592$39.4117.26view

Press Releases about ENDP :

    Quarterly/Annual Reports about ENDP:

    News about ENDP:

    Articles On GuruFocus.com
    Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals Feb 24 2015 
    George Soros' Top New Holdings Feb 18 2015 
    Three Pharma Majors In The Run To Acquire Salix Feb 16 2015 
    Pioneer Investments Purchases Time Warner Cable, Kohl's in Q4 Feb 10 2015 
    Larry Robbins Lives Up to Reputation for Investing in Healthcare Sector Dec 01 2014 
    Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium Apr 23 2014 
    H/C -- winner. Down Mar 02 2013 
    greenblatt - low Jan 22 2013 
    comment on ENDP Nov 28 2012 
    comment on ENDP Jul 09 2012 


    More From Other Websites
    Intercept Pharmaceuticals (ICPT): Will It Miss Q4 Earnings? - Analyst Blog Feb 28 2015
    U.S. judge denies Ranbaxy bid to reinstate approvals for Valcyte, Nexium copies Feb 28 2015
    Will Endo Internationa's (ENDP) Beat on Earnings in Q4? - Analyst Blog Feb 27 2015
    ENDO INTERNATIONAL PLC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets,... Feb 27 2015
    Will Stratasys (SSYS) Disappoint this Earnings Season? - Analyst Blog Feb 27 2015
    Veeva (VEEV): Will it Beat Earnings Estimates This Season? - Analyst Blog Feb 27 2015
    Should You Buy Endo International (ENDP) Ahead of Earnings? - Tale of the Tape Feb 27 2015
    What Awaits Keryx Biopharmaceuticals (KERX) this Earnings? - Analyst Blog Feb 26 2015
    Comcast Corporation (CMCSA), Yahoo! Inc. (YHOO): Among Largest New Bets of Billionaire Daniel Och Feb 25 2015
    Soros increases its position in United Continental Holdings Feb 25 2015
    Can Isis Pharmaceuticals (ISIS) Beat Earnings this Season? - Analyst Blog Feb 25 2015
    Soros continues to be bullish on Dow Chemical Feb 24 2015
    Oclaro, Inc. (OCLR): Soros Fund Management’s Latest Acquisition and Other New Positions Feb 24 2015
    How Raleigh's BioDelivery will use $10M it got from partner on pain drug Feb 23 2015
    Hedgies all-in on stocks; here's how to play it Feb 23 2015
    Soros opens a new position in Allergan Feb 23 2015
    Salix break-up fee signals it's serious about playing ball with Valeant Feb 23 2015
    Salix Pharmaceuticals: Will Another Buyer Push Valeant's Bid Higher? Feb 23 2015
    Soros opens new position in LendingClub Feb 23 2015
    BioDelivery Sciences to Receive $10 Million Milestone Payment from Endo Pharmaceuticals Inc. in... Feb 23 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK